Invesaro

Stocks TXMD Earnings

Earnings

TherapeuticsMD, Inc. (TXMD) earnings

Quarterly results of TherapeuticsMD, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.

Free, no password. An email when TXMD files with the SEC.

Next earnings date

TherapeuticsMD, Inc. is expected to report around November 12, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

Latest quarter: Q2 FY2026

In Q2 FY2026 (ended June 30, 2026) TherapeuticsMD, Inc. reported revenue of $869K (-8.7% on the same quarter a year earlier) and net income of $155K (-71.9% on the same quarter a year earlier).

Diluted earnings per share were $0.01 (-80% on the same quarter a year earlier).

Filed with the SEC on August 11, 2026.

Revenue by quarter
Q3 24: $547K $547K Q3 24Q4 24: $667K $667K Q4 24Q1 25: $393K $393K Q1 25Q2 25: $952K $952K Q2 25Q3 25: $784K $784K Q3 25Q4 25: $893K $893K Q4 25Q1 26: $724K $724K Q1 26Q2 26: $869K $869K Q2 26
Net income by quarter
Q3 24: -$609K -$609K Q3 24Q4 24: $252K $252K Q4 24Q1 25: -$653K -$653K Q1 25Q2 25: $551K $551K Q2 25Q3 25: $152K $152K Q3 25Q4 25: -$619K -$619K Q4 25Q1 26: $95K $95K Q1 26Q2 26: $155K $155K Q2 26

Quarter by quarter

QuarterEndedRevenuevs year agoNet incomeEPS
Q2 FY2026June 30, 2026$869K-8.7%$155K$0.01
Q1 FY2026March 31, 2026$724K+84.2%$95K$0.01
Q4 FY2025December 31, 2025$893K+33.9%-$619K-
Q3 FY2025September 30, 2025$784K+43.3%$152K$0.01
Q2 FY2025June 30, 2025$952K-$551K$0.05
Q1 FY2025March 31, 2025$393K--$653K-$0.06
Q4 FY2024December 31, 2024$667K-$252K-
Q3 FY2024September 30, 2024$547K--$609K-$0.05

Fourth quarters are the fiscal year minus the first three, as most companies report no separate Q4 figures.

Results filings

When is TherapeuticsMD, Inc.'s next earnings date?

TherapeuticsMD, Inc. is expected to report around November 12, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

What were TherapeuticsMD, Inc.'s latest quarterly results?

For Q2 FY2026, which ended June 30, 2026, TherapeuticsMD, Inc. reported revenue of $869K and net income of $155K (-71.9% on the same quarter a year earlier). The figures come from its filing with the SEC.

Is TherapeuticsMD, Inc.'s revenue growing?

Revenue in Q2 FY2026 was $869K, down 8.7% from $952K in the same quarter a year earlier.

Get an email when TXMD reports

Follow TXMD and we email you its next results the day they are filed, with the numbers explained.

Free, no password. An email when TXMD files with the SEC.

Source: quarterly figures TherapeuticsMD, Inc. tags in its 10-Q and 10-K filings (SEC EDGAR XBRL). Not investment advice.

Everything about TherapeuticsMD, Inc.